Meiji Yasuda Asset Management Co Ltd. Acquires Shares of 7,927 Ventas, Inc. $VTR

Meiji Yasuda Asset Management Co Ltd. acquired a new stake in Ventas, Inc. (NYSE:VTR) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 7,927 shares of the real estate investment trust’s stock, valued at approximately $704,000.

A number of other hedge funds have also modified their holdings of the stock. Dynamic Wealth Strategies LLC acquired a new stake in Ventas in the 1st quarter valued at $25,000. Wiser Advisor Group LLC acquired a new position in Ventas during the third quarter worth $27,000. Silvant Capital Management LLC acquired a new position in Ventas during the second quarter worth $28,000. Meeder Asset Management Inc. bought a new position in shares of Ventas during the second quarter valued at $30,000. Finally, IFC & Insurance Marketing Inc. acquired a new stake in shares of Ventas in the 4th quarter valued at $30,000. 94.18% of the stock is owned by institutional investors and hedge funds.

Ventas Price Performance

VTR opened at $93.84 on Wednesday. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The stock has a market capitalization of $48.14 billion, a P/E ratio of 173.79, a price-to-earnings-growth ratio of 2.16 and a beta of 0.69. The company’s 50 day simple moving average is $91.76 and its 200-day simple moving average is $87.38. Ventas, Inc. has a one year low of $66.38 and a one year high of $101.60.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.01. The firm had revenue of $1.73 billion for the quarter, compared to the consensus estimate of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.87 EPS. Sell-side analysts anticipate that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The shares were acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.53% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. Mizuho increased their target price on shares of Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. Raymond James Financial initiated coverage on shares of Ventas in a report on Tuesday, June 16th. They set an “outperform” rating and a $94.00 price objective for the company. The Goldman Sachs Group reissued a “buy” rating and issued a $110.00 target price on shares of Ventas in a report on Tuesday, May 19th. JPMorgan Chase & Co. raised their price target on Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Monday, May 11th. Finally, Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday, July 21st. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Ventas presently has a consensus rating of “Moderate Buy” and an average price target of $98.00.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.